Search
All Clinical Trials in Canada
A listing of 3905 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
253 - 264 of 3905
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Recruiting
Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study aims to provide data on the efficacy and safety of upadacitinib at different doses in adult participants with moderate to severe AD.
Upadacitinib is an approved drug for the treatment of moderate to severe atopic dermatitis (AD). This stud... Read More
Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study aims to provide data on the efficacy and safety of upadacitinib at different doses in adult participants with moderate to severe AD.
Upadacitinib is an approved drug for the treatment of moderate to severe atopic dermatitis (AD). This study is conducted in 2 periods. During Period 1, participants are randomly assigned into 1 of 2 groups called treatment arms to receive upadacitinib Dose A or dupilumab Dose A. Based on the participants response to upadacitinib Dose A, they may have their dose increased to upadacitinib Dose B after 2 weeks. In Period 2, participants that completed Period 1 will either remain on their assigned dose or be reassigned to a different dose based on their Eczema Area and Severity Index (EASI) response. Approximately 300 adult participants ages 18 to 64 with moderate to severe AD who are current users of dupilumab and had a history of inadequate response to dupilumab will be enrolled at up to 94 sites worldwide.
The study is comprised of a 35-day Screening Period, an 8-week Open-Label Period 1 and a 24-week Open-Label Period 2 for participants that completed Period 1. Participants will receive upadacitinib oral tablets once daily or dupilumab subcutaneous (SC) injection every other week for 32 weeks and followed for 30 days.
There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires. Read Less
Gender:
ALL
Ages:
Between 18 years and 63 years
Trial Updated:
07/24/2025
Locations: Clinical Trials Institute - Northwest Arkansas /ID# 267290, Fayetteville, Arkansas +95 locations
Clinical Trials Institute - Northwest Arkansas /ID# 267290, Fayetteville, Arkansas
Private Practice - Dr. Tooraj Raoof /ID# 263849, Encino, California
Allergy & Asthma Associates of Southern California - Mission Viejo /ID# 266574, Mission Viejo, California
Dermatologist Medical Group of North County- Profound Research /ID# 266512, Oceanside, California
Stanford University School of Medicine - Redwood City /ID# 263776, Redwood City, California
Integrative Skin Science and Research /ID# 264537, Sacramento, California
West Dermatology La Jolla /ID# 265014, San Diego, California
Clinical Trials Research Institute /ID# 263846, Thousand Oaks, California
Yale University School of Medicine /ID# 263836, New Haven, Connecticut
Clearlyderm Dermatology - West Boca /ID# 264923, Boca Raton, Florida
Skin Care Research Boca Raton /ID# 263733, Boca Raton, Florida
Apex Clinical Trials /ID# 263747, Brandon, Florida
TrueBlue Clinical Research /ID# 265037, Brandon, Florida
Life Clinical Trials /ID# 267195, Coral Springs, Florida
Revival Research - Doral /ID# 263541, Doral, Florida
Skin Care Research - Hollywood /ID# 263739, Hollywood, Florida
Solutions Through Advanced Research /ID# 263392, Jacksonville, Florida
GSI Clinical Research, LLC /ID# 263760, Margate, Florida
Quality Research of South Florida /ID# 266496, Miami Lakes, Florida
Research Associates of South Florida /ID# 267291, Miami, Florida
International Dermatology Research /ID# 264961, Miami, Florida
Sullivan Dermatology /ID# 263537, Miami, Florida
Lenus Research and Medical Group /ID# 263779, Miami, Florida
Global Clinical Professionals (GCP) /ID# 266474, Saint Petersburg, Florida
Skin Care Research - Tampa /ID# 263750, Tampa, Florida
Alliance Clinical Research of Tampa /ID# 264531, Tampa, Florida
Centricity Research Columbus Dermatology /ID# 266529, Columbus, Georgia
Cleaver Medical Group Dermatology /ID# 263788, Dawsonville, Georgia
Georgia Skin & Cancer Clinic /ID# 267199, Savannah, Georgia
Treasure Valley Medical Research /ID# 263738, Boise, Idaho
DeNova Research /ID# 264513, Chicago, Illinois
Northwestern University Feinberg School of Medicine /ID# 264983, Chicago, Illinois
Dawes Fretzin, LLC /ID# 264534, Indianapolis, Indiana
Options Research Group /ID# 264564, West Lafayette, Indiana
Dermatology Specialists Research (DS Research) - Kentucky /ID# 263388, Louisville, Kentucky
Velocity Clinical Research at The Dermatology Clinic - Baton Rouge /ID# 267169, Baton Rouge, Louisiana
Boston Specialists /ID# 265810, Boston, Massachusetts
Beth Israel Deaconess Medical Center /ID# 263703, Boston, Massachusetts
Beacon Clinical Research /ID# 263843, Quincy, Massachusetts
Great Lakes Research Group - Bay City /ID# 263535, Bay City, Michigan
Henry Ford Medical Center - New Center One /ID# 263522, Detroit, Michigan
Onyx Clinical Research - Flint - South Linden Road /ID# 267773, Flint, Michigan
MediSearch Clinical Trials /ID# 263579, Saint Joseph, Missouri
Physician Research Collaboration, LLC /ID# 263583, Lincoln, Nebraska
Skin Specialists /ID# 263345, Omaha, Nebraska
Skin Cancer and Dermatology Institute - Reno /ID# 263771, Reno, Nevada
Dartmouth Hitchcock Medical Center - Old Etna Road /ID# 263840, Lebanon, New Hampshire
Forest Hills Dermatology Group @ Union Turnpike /ID# 263755, Kew Gardens, New York
Equity Medical, LLC /ID# 265814, New York, New York
Weill Cornell Medicine /ID# 265793, New York, New York
Piedmont Plastic Surgery and Dermatology /ID# 266545, Huntersville, North Carolina
Vital Prospects Clinical Research Institute - Tulsa /ID# 263645, Tulsa, Oklahoma
Oregon Health and Science University /ID# 263736, Portland, Oregon
Dermatology Partners /ID# 264972, Philadelphia, Pennsylvania
University of Pittsburgh Medical Center /ID# 264526, Pittsburgh, Pennsylvania
Dermatology Associates of Plymouth Meeting /ID# 267286, Plymouth Meeting, Pennsylvania
Medical University of South Carolina /ID# 263655, Charleston, South Carolina
ADCS - Spartanburg /ID# 267185, Spartanburg, South Carolina
Arlington Research Center, Inc /ID# 263665, Arlington, Texas
Orion Clinical Research /ID# 263658, Austin, Texas
Bellaire Dermatology Associates /ID# 263794, Bellaire, Texas
Studies in Dermatology LLC /ID# 263335, Cypress, Texas
Dermatology Treatment and Research Center /ID# 265812, Dallas, Texas
Modern Research Associates /ID# 263852, Dallas, Texas
The Dermatology Institute of South Texas /ID# 267332, McAllen, Texas
Texas Dermatology Research Center /ID# 264528, Plano, Texas
Stride Clinical Research /ID# 267331, Sugar Land, Texas
The Woodlands Dermatology Associates /ID# 266547, The Woodlands, Texas
Dermatology Associates of Tyler /ID# 264980, Tyler, Texas
West Virginia Research Institute - Morgantown /ID# 264930, Morgantown, West Virginia
Dermatology Research Institute - Blackfoot Trail /ID# 270450, Calgary, Alberta
Stratica Medical /ID# 270466, Edmonton, Alberta
Centre de Recherche Saint-Louis /ID# 271083, Québec, Quebec
Centro de Inmunología y Genética CIGE SAS /ID# 266200, Medellín, Antioquia
Centro Integral de Reumatología del Caribe SAS - Circaribe SAS /ID# 265088, Barranquilla, Atlantico
Centro de Investigacion en Reumatologia y especialidades Medicas S.A.S- CIREEM /ID# 265092, Bogotá, Cundinamarca
Unidad Integral de Endocrinologia (UNIENDO) /ID# 266970, Bogotá, Cundinamarca
Ichinomiya Municipal Hospital /ID# 265068, Ichinomiya, Aichi
Takeoka Dermatology Clinic /ID# 264055, Marugame, Kagawa
Kawasaki Medical School Hospital /ID# 266164, Kurashiki, Okayama
Dokkyo Medical University Hospital /ID# 265431, Mibu, Tochigi
Tachikawa Dermatology Clinic /ID# 271912, Tachikawa-shi, Tokyo
Katahira Dermatology Urology Clinic /ID# 264403, Kagoshima, Not set
NTT Medical Center Tokyo /ID# 265104, Tokyo, Not set
Teikyo University Hospital /ID# 265126, Tokyo, Not set
Korea University Ansan Hospital /ID# 263330, Ansan-si, Gyeonggido
Soon Chun Hyang University Hospital Bucheon /ID# 263331, Bucheon-si, Gyeonggido
Ajou University Hospital /ID# 263328, Suwon-si, Gyeonggido
Seoul National University Hospital /ID# 263329, Seoul, Seoul Teugbyeolsi
Konkuk University Medical Center /ID# 263327, Seoul, Seoul Teugbyeolsi
SCB Research Center /ID# 263217, Bayamon, Not set
Private Practice - Dr. Samuel Sanchez /ID# 263199, Caguas, Not set
Private Practice - Dr. Alma Cruz /ID# 263216, Carolina, Not set
Clinical Research Puerto Rico /ID# 263197, San Juan, Not set
GCM Medical Group, PSC /ID# 263218, San Juan, Not set
Caribbean Medical Research Center /ID# 267163, San Juan, Not set
Conditions: Atopic Dermatitis
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Recruiting
This phase II trial compares mosunetuzumab to the usual treatment (rituximab) for improving survival in patients with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). Rituximab and mosunetuzumab are monoclonal antibodies. They bind to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Mosunetuzumab may be more effective at extending survival in patients with NLPHL than the usual... Read More
This phase II trial compares mosunetuzumab to the usual treatment (rituximab) for improving survival in patients with nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL). Rituximab and mosunetuzumab are monoclonal antibodies. They bind to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This may help the immune system kill cancer cells. Mosunetuzumab may be more effective at extending survival in patients with NLPHL than the usual approach with rituximab. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/24/2025
Locations: City of Hope Comprehensive Cancer Center, Duarte, California +33 locations
City of Hope Comprehensive Cancer Center, Duarte, California
UM Sylvester Comprehensive Cancer Center at Aventura, Aventura, Florida
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida
UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs, Florida
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida
UM Sylvester Comprehensive Cancer Center at Doral, Doral, Florida
UM Sylvester Comprehensive Cancer Center at Hollywood, Hollywood, Florida
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida
UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
University of Kansas Cancer Center, Kansas City, Kansas
University of Kansas Cancer Center-Overland Park, Overland Park, Kansas
University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas
University of Kansas Cancer Center - North, Kansas City, Missouri
University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri
University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey
Memorial Sloan Kettering Monmouth, Middletown, New Jersey
Memorial Sloan Kettering Bergen, Montvale, New Jersey
Memorial Sloan Kettering Commack, Commack, New York
Memorial Sloan Kettering Westchester, Harrison, New York
Memorial Sloan Kettering Cancer Center, New York, New York
Memorial Sloan Kettering Nassau, Uniondale, New York
Wake Forest University Health Sciences, Winston-Salem, North Carolina
University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio
University of Cincinnati Cancer Center-West Chester, West Chester, Ohio
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
M D Anderson Cancer Center, Houston, Texas
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
University of Virginia Cancer Center, Charlottesville, Virginia
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia
University Health Network-Princess Margaret Hospital, Toronto, Ontario
Conditions: Nodular Lymphocyte Predominant B-Cell Lymphoma, Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma, Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Recruiting
This is a Phase III, randomized, open-label multicenter study that will evaluate the efficacy and safety of giredestrant compared with fulvestrant, both in combination with the investigator's choice of a CDK4/6 inhibitor (palbociclib, ribociclib or abemaciclib), in participants with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer who have developed resistance to adjuvant endocrine therapy.
This is a Phase III, randomized, open-label multicenter study that will evaluate the efficacy and safety of giredestrant compared with fulvestrant, both in combination with the investigator's choice of a CDK4/6 inhibitor (palbociclib, ribociclib or abemaciclib), in participants with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer who have developed resistance to adjuvant endocrine therapy. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/24/2025
Locations: Southern Cancer Center, Daphne, Alabama +341 locations
Southern Cancer Center, Daphne, Alabama
Sutter Auburn Faith Hospital, Auburn, California
La Hematology Oncology Medical Group, Glendale, California
Marin Cancer Care Inc, Greenbrae, California
Kaiser Permanente - Harbor City, Harbor City, California
USC Norris Comprehensive Cancer Center, Los Angeles, California
USC Norris Cancer Center, Newport Beach, California
Sutter Medical Group, Roseville Clinic, Roseville, California
Sutter Health Medical Center, Sacramento, California
The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Cente, Torrance, California
Rocky Mountain Cancer Centers, Littleton, Colorado
Georgetown University Medical Center, Washington, District of Columbia
MedStar Washington Hosp Center, Washington, District of Columbia
AdventHealth Altamonte, Altamonte Springs, Florida
Florida Cancer Specialists - Fort Myers (Gladiolus Dr), Fort Myers, Florida
Cancer Specialists of North Florida, Jacksonville, Florida
Comprehensive Hematology Oncology, Saint Petersburg, Florida
Florida Cancer Specialists - Tampa, Tampa, Florida
Florida Cancer Specialists - EAST - SCRI - PPDS, West Palm Beach, Florida
Grady Health System, Atlanta, Georgia
Winship Cancer Institute of Emory University, Atlanta, Georgia
Advocate Lutheran General Hospital, Park Ridge, Illinois
Springfield Clinic, Springfield, Illinois
Mission Cancer + Blood - IMMC, Des Moines, Iowa
Baptist Health Lexington, Lexington, Kentucky
Baptist Health Hamburg, Lexington, Kentucky
Baptist Health Louisville, Louisville, Kentucky
New England Cancer Specialists, Scarborough, Maine
Maryland Oncology Hematology, Annapolis, Maryland
Frederick Health Hospital, Frederick, Maryland
Dana Farber Cancer Institute, Boston, Massachusetts
Henry Ford Hospital, Detroit, Michigan
HCA Midwest Division, Kansas City, Missouri
Cancer Care Center of O'Fallon, O'Fallon, Missouri
Oncology Hematology West - Legacy, Omaha, Nebraska
Astera Cancer Care East Brunswick, East Brunswick, New Jersey
Capital Health Regional Medical Center, Pennington, New Jersey
Queens Hospital Cancer Center, Jamaica, New York
Duke Women Cancer Care, Raleigh, North Carolina
Oncology Hematology Care, Cincinnati, Ohio
Asante Rogue Regional Medical Center, Medford, Oregon
Alliance Cancer Specialists, Bensalem, Pennsylvania
Ann B. Barshinger Cancer Institute, Lancaster, Pennsylvania
Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit, Philadelphia, Pennsylvania
WellSpan Oncology Research, York, Pennsylvania
Brown University Health, Providence, Rhode Island
Medical University of South Carolina, Charleston, South Carolina
Avera Cancer Institute - Aberdeen, Aberdeen, South Dakota
Avera Cancer Institute, Sioux Falls, South Dakota
West Cancer Center, Germantown, Tennessee
SCRI Oncology Partners, Nashville, Tennessee
Texas Oncology Cancer Center, Austin, Texas
JPS Oncology & Infusion Center, Fort Worth, Texas
Texas Oncology - DFW, Irving, Texas
Virginia Cancer Specialists, PC, Fairfax, Virginia
Virginia Commonwealth University - Massey Cancer Center, Richmond, Virginia
Northwest Medical Specialties, Tacoma, Washington
West Virginia University Hospitals Inc, Morgantown, West Virginia
Aurora BayCare Medical Center, Green Bay, Wisconsin
Aurora St Lukes Medical Center, Milwaukee, Wisconsin
Inst. de Oncologia Angel H. Roffo, Buenos aires, Not set
Fundación CENIT para la Investigación en Neurociencias, Ciudad Autonoma Buenos Aires, Not set
Centro Oncologico Korben, Ciudad Autonoma Buenos Aires, Not set
Sanatorio Allende, Cordoba, Not set
Centro Oncologico Riojano Integral (CORI), La Rioja, Not set
Hospital Alemán, Recoleta, Not set
Instituto de Oncología de Rosario, Rosario, Not set
Sanatorio Parque S.A., Rosario, Not set
Hospital Provincial del Centenario, Rosario, Not set
Centro Oncológico de Excelencia, San Juan, Not set
Northern Beaches Hospital, Frenchs Forest, New South Wales
Nepean Hospital, Kingswood, New South Wales
Mater Hospital, North Sydney, New South Wales
University of the Sunshine Coast, Sippy Downs, Queensland
Mater Misericordiae Limited, South Brisbane, Queensland
Cancer Research SA, Adelaide, South Australia
Barwon Health, Geelong, Victoria
Sunshine Hospital, St Albans, Victoria
South West Healthcare, Warrnambool, Victoria
Lkh-Univ. Klinikum Graz, Graz, Not set
Medical University Innsbruck, Innsbruck, Not set
Ordensklinikum Linz Barmherzige Schwestern, Linz, Not set
Oö. Gesundheits- und Spitals-AG/LKH Steyr, Steyr, Not set
Medizinische Universität Wien, Wien, Not set
Cliniques Universitaires St-Luc, Bruxelles, Not set
GHdC Site Les Viviers, Charleroi, Not set
UZ Gent, Gent, Not set
UZ Leuven Gasthuisberg, Leuven, Not set
CHU de Liège (Sart Tilman), Liège, Not set
AZ St Maarten Campus Leopoldstr, Mechelen, Not set
Clinique Ste-Elisabeth, Namur, Not set
ZAS Sint Augustinus Wilrijk, Wilrijk, Not set
Obras Sociais Irma Dulce - Osid, Salvador, Bahia
Crio - Centro Regional Integrado de Oncologia, Fortaleza, Ceará
Hospital Sírio-Libanês, Brasilia, Distrito Federal
CEDOES - Diagnóstico e Pesquisa, Vitoria, Espírito Santo
Hospital Araujo Jorge, Goiania, Goiás
Hospital Sao Domingos, Sao Luis, Maranhão
Hospital do Cancer de Pernambuco - HCP, Recife, Pernambuco
Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda, Ijui, Rio Grande Do Sul
Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul
Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul
Hospital Sao Lucas - PUCRS, Porto Alegre, Rio Grande Do Sul
Hospital Nossa Senhora da Conceicao, Porto Alegre, Rio Grande Do Sul
Hospital de Cancer de Barretos, Barretos, São Paulo
Hospital Amaral Carvalho, Jau, São Paulo
Hospital Sírio-Libanês, Sao Paulo, São Paulo
Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda, Sao Paulo, São Paulo
Hospital A. C. Camargo, Sao Paulo, São Paulo
Instituto D'Or de Pesquisa e Ensino, Rio de Janeiro, Not set
Cross Cancer Institute, Edmonton, Alberta
Royal Victoria Regional Health Centre, Barrie, Ontario
Credit Valley Hospital/Carlo Fidani Peel Regional Cancer Centre, Mississauga, Ontario
Lakeridge Health Oshawa, Oshawa, Ontario
Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario
North York General Hospital, Toronto, Ontario
Princess Margaret Cancer Center, Toronto, Ontario
CIUSSS du Saguenay Lac-Saint-Jean, Chicoutimi Hospital, Chicoutimi, Quebec
CISSS Chaudière-Appalaches, Levis, Quebec
Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec
McGill University Health Centre - Glen Site, Montreal, Quebec
CHU de Québec - Hôpital du Saint-Sacrement, Quebec City, Quebec
Hopital regional de saint jerome, Saint-jerome, Quebec
Centre hospitalier regional de Trois-Rivieres, Trois-Rivieres, Quebec
Allan Blair Cancer Centre, Regina, Saskatchewan
Saskatoon Cancer Centre, Saskatoon, Saskatchewan
Hospital las Higueras, Concepción, Región Bio Bio
Oncovida, Providencia, Not set
Clínica Puerto Montt, Puerto Montt, Not set
Centro De Cancer Universidad Catolica, Santiago, Not set
Instituto Nacional del Cancer, Santiago, Not set
Icegclinic, Santiago, Not set
Beijing Cancer Hospital, Beijing, Not set
the First Hospital of Jilin University, Changchun City, Not set
Hunan Cancer Hospital, Changsha CITY, Not set
West China Hospital of Sichuan University, Chengdu City, Not set
Sichuan Provincial People's Hospital, Chengdu, Not set
The First Affiliated Hospital, Chongqing Medical University, Chongqing, Not set
Fujian Medical University Union Hospital, Fuzhou City, Not set
No. 900 Hospital (Fuzhou General Hospital), Fuzhou City, Not set
Cancer Center, Sun Yat-sen University of Medical Sciences, Guangzhou City, Not set
The Second Affiliated Hospital of Zhejiang University College, Hangzhou, Not set
Harbin Medical University Cancer Hospital, Harbin, Not set
Jinan Central Hospital, Jinan City, Not set
Shandong Cancer Hospital, Jinan, Not set
The First People's Hospital of Yunnan Province, Kunming City, Not set
The First Affiliated Hospital to Henan University of Science and Technology, Luoyang, Not set
Guangxi Cancer Hospital of Guangxi Medical University, Nanning, Not set
Fudan University Shanghai Cancer Center, Shanghai City, Not set
Zhongshan Hospital Fudan University, Shanghai, Not set
Shanxi Province Cancer Hospital, Taiyuan City, Not set
Taizhou Hospital of Zhejiang Province, Taizhou, Not set
Tianjin Cancer Hospital, Tianjin, Not set
The Tumor Hospital of Xinjiang Medical University, Urumqi, Not set
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan City, Not set
Hubei Cancer Hospital, Wuhan, Not set
The Second Affiliated Hospital of Xi'an Jiao Tong University, Xi'an City, Not set
Xi'an International Medical Center Hospital, Xian, Not set
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Not set
Zhejiang Cancer Hospital, Zhejiang, Not set
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Not set
Fundación CTIC - Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo, Bogota, D.C., Not set
IPS Salud SURA Chipichape Cali, Cali, Not set
Oncomedica S.A., Monteria, Not set
Sociedad de Oncología y hematología del Cesar Ltda, Valledupar, Not set
Clinica CIMCA, San José, Not set
ICIMED Instituto de Investigación en Ciencias Médicas, San José, Not set
Proclinical Pharma, San José, Not set
Kuopio Uni Hospital, Kuopio, Not set
Tampere University Hospital, Tampere, Not set
ICO Paul Papin, Angers, Not set
Institut Sainte Catherine, Avignon, Not set
Hopital Jean Minjoz, Besancon, Not set
Centre Francois Baclesse, Caen, Not set
Centre Jean Perrin, Clermont Ferrand, Not set
Centre Hospitalier Saint Louis, La Rochelle, Not set
Centre Oscar Lambret, Lille, Not set
Centre Leon Berard, Lyon, Not set
Centre Cancerologie Grand Montpellier, Montpellier, Not set
Institut Jean Godinot, Reims CEDEX, Not set
Centre Eugene Marquis, Rennes, Not set
IUCT Oncopole, Toulouse, Not set
Gustave Roussy, Villejuif, Not set
Sozialstiftung Bamberg, Klinikum am Bruderwald, Gynäkologie, Bamberg, Not set
DONAU ISAR Klinikum Deggendorf, Deggendorf, Not set
Gynonco Düsseldorf, MVZ Medical Center GmbH, Düsseldorf, Not set
Universitätsklinikum Erlangen, Erlangen, Not set
Kliniken Essen-Mitte, Essen, Not set
Praxis für Interdisziplinäre Onkologie und Hämatologie GbR, Freiburg, Not set
Nationales Centrum für Tumorerkrankungen (NCT), Heidelberg, Not set
Universitätsklinikum des Saarlandes, Homburg/Saar, Not set
St. Elisabeth Krankenhaus Köln GmbH, Koeln, Not set
Rotkreuzklinikum München, Muenchen, Not set
Brustzentrum Rhein-Ruhr Servicegesellschaft mbH, Mönchengladbach, Not set
Anticancer Hospital Ag. Savas, Athens, Not set
Aretaieio Hospital of Athens, Athina, Not set
University Hospital of Larissa, Larissa, Not set
University Hospital of Patras Medical Oncology, Patras, Not set
European Interbalkan Medical Center, Thessaloniki, Not set
Celan S.A., Ciudad de Guatemala, Not set
INTEGRA Cancer Institute, Ciudad de Guatemala, Not set
Onco Go, S.A., Ciudad de Guatemala, Not set
Medi-k, ciudad de Guatemala, Not set
Grupo Angeles, Guatemala City, Not set
Oncomedica, Guatemala, Not set
Centro Medico Integral de Cancerologia CEMIC, Salcajá, Not set
Pamela Youde Nethersole Eastern Hospital, Hong Kong, Not set
Queen Mary Hospital, Hong Kong, Not set
Orszagos Onkologiai Intezet, Budapest, Not set
Bács-Kiskun Vármegyei Oktatókórház, Kecskemét, Not set
B-A-Z Vármegyei Központi Kórház és Egyetemi Oktatókórház, Miskolc, Not set
Nograd Varmegyei Szent Lazar Korhaz, Salgótarján, Not set
Max Super Speciality Hospital, New Delhi, Delhi
HealthCare Global Enterprises Limited, Banglore, Karnataka
MVR Cancer Centre and Research Institute, Kozhikode, Kerala
Regional Cancer Centre, Trivandrum, Kerala
Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, Maharashtra
Grant Medical Foundation, Ruby Hall Clinic, Pune, Maharashtra
Sahyadri Speciality Hospital, Pune, Maharashtra
Sunact Cancer Institute, Thane, Maharashtra
Hadassah Ein Karem Hospital, Jerusalem, Not set
Rabin Medical Center, Petah Tikva, Not set
Sheba MC, Ramat Gan, Not set
Sourasky Medical Center, Tel-Aviv, Not set
Azienda Ospedaliera di Rilievo Nazionale e di Alta Specialita San Giuseppe Moscati, Avellino, Campania
Azienda Ospedaliera Universitaria Federico II, Napoli, Campania
Policlinico S.Orsola-Malpighi, Bologna, Emilia-Romagna
I.R.S.T Srl IRCCS, Meldola, Emilia-Romagna
A.O. Universitaria Di Parma, Parma, Emilia-Romagna
RCCS - Centro di Riferimento, Aviano (PN), Friuli-Venezia Giulia
A.O. Universitaria S. Maria Della Misericordia Di Udine, Udine, Friuli-Venezia Giulia
Policlinico Universitario Agostino Gemelli, Roma, Lazio
Università Campus Bio-Medico di Roma, Roma, Lazio
Asst Papa Giovanni XXIII, Bergamo, Lombardia
Asst Degli Spedali Civili Di Brescia, Brescia, Lombardia
Irccs Istituto Nazionale Dei Tumori (Int), Milano, Lombardia
Istituto Clinico Humanitas, Rozzano, Lombardia
Ospedale Di Macerata, Macerata, Marche
A.O.U. Maggiore della Carità, Novara, Piemonte
Presidio Ospedaliero di Summa-Perrino, Brindisi, Puglia
Humanitas Centro Catanese Di Oncologia, Misterbianco (CT), Sicilia
Azienda Ospedaliera Universitaria Careggi, Florence, Toscana
IOV - Istituto Oncologico Veneto - IRCCS, Padova, Veneto
University of Nairobi - Institute of Tropical and Infectious Diseases, Nairobi, Not set
Kyungpook National University Chilgok Hospital, Daegu, Not set
Seoul National University Bundang Hospital, Seongnam-si, Not set
Korea University Anam Hospital, Seoul, Not set
Seoul National University Hospital, Seoul, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Asan Medical Center, Seoul, Not set
Gangnam Severance Hospital, Seoul, Not set
Ewha Womans University Mokdong Hospital, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Ulsan University Hosiptal, Ulsan, Not set
Panamerican Clinical Research S.A de C.V., Guadalajara, Jalisco
RENATI INNOVATION S.A.P.I. de C.V, Guadalajara, Jalisco
Productos y Servicios Oncologicos Acacias SA de CV, Ciudad de México, Mexico CITY (federal District)
Centro Oncológico Hematológico Roma, Mexico City, Mexico CITY (federal District)
Hospital Zambrano Hellion TecSalud, Monterrey, Nuevo LEON
Centro de Investigacion Clinica de Oaxaca, Oaxaca de Juárez, Oaxaca
PanAmerican Clinical Research, Querétaro, Queréaro, Queretaro
CENEIT Oncologicos, Mexico City, Not set
Centro Medico Dalinde, Mexico City, Not set
Christchurch Hospital, Christchurch, Not set
Palmerston North Hospital, Palmerston North, Not set
Whangarei Hospital, Whangarei, Not set
Centro Medico Monte Carmelo, Arequipa, Not set
Hospital Goyeneche, Arequipa, Not set
Clínica Santa Beatriz, Lima, Not set
Hospital Nacional Arzobispo Loayza, Lima, Not set
Oncosalud Sac, Lima, Not set
Instituto Nacional de Enfermedades Neoplasicas, Lima, Not set
Clinica Internacional, Sede San Borja, Lima, Not set
Instituto Peruano de Oncología y Radioterapia, Lima, Not set
Clinica San Antonio;Investigaciones Trujillo S.A.C., Trujillo, Not set
Clinica Peruana Americana, Trujillo, Not set
Instituto Regional de Enfermedades Neoplasicas - IREN Norte, Trujillo, Not set
Instytut "Centrum Zdrowia Matki Polki", ?ód?, Not set
Centrum Onkologii im. Prof. Franciszka ?ukaszczyka, Bydgoszcz, Not set
Szpital Morski Im. Pck, Gdynia, Not set
Narodowy Instytut Onkologii Odzia? w Gliwicach, Gliwice, Not set
?wi?tokrzyskie Centrum Onkologii, Kielce, Not set
Przychodnia Lekarska KOMED, Roman Karaszewski, Konin, Not set
Szpital Wojewódzki im. Miko?aja Kopernika, Koszalin, Not set
Centrum Onkologii Ziemi Lubelskiej im. sw. Jana z Dukli, Lublin, Not set
Mazowiecki Szpital Wojewódzki im. ?w. Jana Paw?a II, Siedlce, Not set
Zachodniopomorskie Centrum Onkologii, Szczecin, Not set
Narodowy Inst.Onkologii im.Sklodowskiej-Curie Panstw.Inst.Bad, Warszawa, Not set
IPO de Coimbra, Coimbra, Not set
Hospital de S. Francisco Xavier, Lisboa, Not set
Hospital da Luz, Lisboa, Not set
IPO do Porto, Porto, Not set
CHVNG/E_Unidade 1, Vila Nova de Gaia, Not set
PanOncology Trials, San Juan, Not set
Spitalul Clinic Filantropia, Bucuresti, Not set
Amethyst Cluj, Cluj County, Not set
Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj Napoca, Cluj Napoca, Not set
Centrul de Oncologie Sfantul Nectarie, Craiova, Not set
Institutul Regional de Oncologie Iasi, Iasi, Not set
Centrul de Oncologie Oncohelp, Timisoara, Not set
National University Hospital, Singapore, Not set
National Cancer Centre, Singapore, Not set
Icon Cancer Centre Gleneagles, Singapore, Not set
Institute of Oncology Ljubljana, Ljubljana, Not set
Cancercare Rondebosch Oncology, Cape Town, Not set
Cancercare, Port Elizabeth, Not set
Steve Biko Academic Hospital, Pretoria, Not set
Institut Catala d?Oncologia Hospital Germans Trias i Pujol, Badalona, Barcelona
Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Sant Andreu de La Barca, Barcelona
Hospital de Jerez de la Frontera, Jerez de La Frontera, Cadiz
Hospital Quiron de Madrid, Pozuelo de Alarcon, Madrid
Hospital Universitario Virgen de La Arrixaca, EL Palmar (EL Palmar), Murcia
Hospital Alvaro Cunqueiro, Vigo, Pontevedra
Hospital Universitari Dexeus - Grupo Quironsalud, Barcelona, Not set
Hospital Juan Ramon Jimenez, Huelva, Not set
Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico, Jaen, Not set
Centro Oncologico MD Anderson Internacional, Madrid, Not set
Hospital de Madrid Norte Sanchinarro- Centro Integral Oncologico Clara Campal, Madrid, Not set
Hospital Universitario Virgen Macarena, Sevilla, Not set
Hospital Universitario Virgen del Rocio, Sevilla, Not set
Instituto Valenciano Oncologia, Valencia, Not set
Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia, Valencia, Not set
Hsin-Chu Branch of National Taiwan University Hospital, Hsinchu City, Not set
China Medical University Hospital, Taichung, Not set
Koo Foundation Sun Yat-Sen Cancer Center, Taipei City, Not set
Veterans General Hospital, Taipei, Not set
National Taiwan Uni Hospital, Taipei, Not set
Veterans General Hospital - Taichung, Xitun Dist., Not set
Chulalongkorn Hospital, Bangkok, Not set
National Cancer Institute, Bangkok, Not set
Rajavithi Hospital, Bangkok, Not set
Chulabhorn Hospital, Lak Si, Not set
Maharaj Nakorn Chiang Mai Hospital;Depart of Radiology, Muang Chiang MAI Delivery Branch 3, Not set
Songklanagarind Hospital, Songkhla, Not set
Sakarya Training and Research Hospital, Adapazar?, Not set
Ankara City Hospital, Ankara, Not set
Bakirkoy Dr. Sadi Konuk Egitim ve Arastirma Hastanesi, Tibbi Onkoloji, Bakirkoy / Istanbul, Not set
Katip Celebi University Ataturk Training and Research Hospital, Izmir, Not set
Goztepe Prof.Dr. Suleyman Yalcin City Hospital, Kadiköy, Not set
Mersin City Education and Research Hospital, Mersin, Not set
Medikal Park Samsun, Samsun, Not set
Hacettepe Uni Medical Faculty Hospital, Sihhiye/Ankara, Not set
Conditions: Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
A Study to Evaluate the Efficacy and Safety of Frexalimab, SAR442970, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
Recruiting
This is a parallel, Phase 2a, double-blind, 6-arm study for the treatment of primary focal segmental glomerulosclerosis (FSGS) or primary minimal change disease (MCD).
The purpose of this study is to measure the change in proteinuria and its impact on the rates of remission of nephrotic syndrome with frexalimab, SAR442970, or rilzabrutinib compared with placebo in participants with primary FSGS or primary MCD aged 16 to 75 years.
Study details for each participant include:
The study duration... Read More
This is a parallel, Phase 2a, double-blind, 6-arm study for the treatment of primary focal segmental glomerulosclerosis (FSGS) or primary minimal change disease (MCD).
The purpose of this study is to measure the change in proteinuria and its impact on the rates of remission of nephrotic syndrome with frexalimab, SAR442970, or rilzabrutinib compared with placebo in participants with primary FSGS or primary MCD aged 16 to 75 years.
Study details for each participant include:
The study duration will be up to 76 weeks. The treatment duration will be 24 weeks. There will be up to 18 visits. Read Less
Gender:
ALL
Ages:
Between 16 years and 75 years
Trial Updated:
07/24/2025
Locations: Investigational Site Number: 8400007, Birmingham, Alabama +54 locations
Investigational Site Number: 8400007, Birmingham, Alabama
Investigational Site Number : 8400015, Orange, California
Investigational Site Number : 8400012, San Francisco, California
Investigational Site Number : 8400014, Chicago, Illinois
Investigational Site Number : 8400017, Hinsdale, Illinois
Investigational Site Number : 8400010, Ann Arbor, Michigan
Investigational Site Number : 8400019, Edina, Minnesota
Investigational Site Number : 8400018, Las Vegas, Nevada
Investigational Site Number : 8400001, New York, New York
Investigational Site Number : 8400005, El Paso, Texas
Investigational Site Number: 8400016, Houston, Texas
Investigational Site Number : 0320002, Cordoba, Córdoba
Investigational Site Number : 0320001, Buenos Aires, Not set
Investigational Site Number : 0360003, Canberra, Australian Capital Territory
Investigational Site Number : 0360001, Parkville, Victoria
Investigational Site Number : 0760002, Sao Paulo, São Paulo
Investigational Site Number: 0760001, São Paulo, Not set
Investigational Site Number : 1240001, Montreal, Quebec
Investigational Site Number : 1240006, Quebec City, Quebec
Investigational Site Number : 1520002, Santiago, Reg Metropolitana De Santiago
Investigational Site Number : 1520003, Temuco, Not set
Investigational Site Number : 1560001, Beijing, Not set
Investigational Site Number : 1560003, Chengdu, Not set
Investigational Site Number : 1560004, Shanghai, Not set
Investigational Site Number : 2030002, Olomouc, Not set
Investigational Site Number : 2030001, Prague, Not set
Investigational Site Number : 2500002, Créteil, Not set
Investigational Site Number : 2500001, Paris, Not set
Investigational Site Number : 2760002, Berlin, Not set
Investigational Site Number : 2760003, Hannover, Not set
Investigational Site Number : 3000002, Athens, Not set
Investigational Site Number : 3000001, Heraklion, Not set
Investigational Site Number : 3480001, Budapest, Not set
Investigational Site Number : 3800002, Florence, Firenze
Investigational Site Number : 3800003, Naples, Napoli
Investigational Site Number : 3800001, Brescia, Not set
Investigational Site Number : 4840001, Mexico City, Ciudad De Mexico
Investigational Site Number : 4840003, Monterrey, Nuevo León
Investigational Site Number : 5280001, Amsterdam, Not set
Investigational Site Number : 6160002, Opole, Not set
Investigational Site Number : 6200001, Matosinhos, Not set
Investigational Site Number : 6200002, Porto, Not set
Investigational Site Number : 7030003, Banská Bystrica, Not set
Investigational Site Number : 7030001, Martin, Not set
Investigational Site Number : 7240001, Barcelona, Barcelona [Barcelona]
Investigational Site Number : 7240004, Barcelona, Catalunya [Cataluña]
Investigational Site Number : 7240005, Seville, Sevilla
Investigational Site Number : 7240002, Córdoba, Not set
Investigational Site Number : 7240003, Valencia, Not set
Investigational Site Number : 1580001, Taichung, Not set
Investigational Site Number : 1580002, Taipei City, Not set
Investigational Site Number : 7920001, Izmit, Not set
Investigational Site Number : 7920002, Kayseri, Not set
Investigational Site Number : 8260001, Leicester, Leicestershire
Investigational Site Number : 8260004, Salford, Manchester
Conditions: Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion
Prospective Clinical Assessment Study in Children With Hypochondroplasia
Recruiting
This is a long-term, multicenter, non-interventional study of children ages 2.5 to \<17 years with hypochondroplasia (HCH).
This is a long-term, multicenter, non-interventional study of children ages 2.5 to \<17 years with hypochondroplasia (HCH). Read Less
Gender:
ALL
Ages:
Between 30 months and 16 years
Trial Updated:
07/24/2025
Locations: UCSF Benioff Children's Hospital, Oakland, California +24 locations
UCSF Benioff Children's Hospital, Oakland, California
Childrens Hospital Colorado, Aurora, Colorado
Children's National Hospital, Washington DC, District of Columbia
Johns Hopkins School of Medicine, Baltimore, Maryland
University of Missouri, Columbia, Missouri
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Vanderbilt University Medical Center, Nashville, Tennessee
University of Wisconsin Madison - Waisman Center Bone Dysplasia Clinic, Madison, Wisconsin
Murdoch Children's Research Institute, Parkville, Victoria
London Health Sciences Centre - Children's Hospital of Western Ontario, London, Ontario
Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario
Université de Montréal - Centre Hospitalier Universitaire Sainte-Justine, Montréal, Quebec
Hôpital Femme Mère Enfant HCL, Bron, Not set
Hôpital Necker-Enfants Malades, Paris, Not set
Centre Hospitalier Universitaire (CHU) de Toulouse - Hôpital des Enfants, Toulouse, Not set
Haukeland University Hospital, Bergen, Not set
Paediatric Clinical Research Unit at Oslo University Hospital, Oslo, Not set
Hospital Pediátrico de Coimbra, Coimbra, Not set
KK Women's and Children's Hospital, Singapore, Not set
Hospital Vithas San Jose, Vitoria-gasteiz, Not set
Astrid Lindgren Children's Hospital, Solna, Not set
The Portland Hospital for Women and Children, London, England
Manchester University, Manchester, England
Sheffield Children's NHS Foundation Trust, Sheffield, England
Glasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, Scotland
Conditions: Hypochondroplasia
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Recruiting
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative colitis (UC). Another aim is to learn about treatment with Vedolizumab alone after the double treatment.
All participants will receive vedolizumab together with tofacitinib for 8 weeks and will be checked for response. Participants who show a response to the treatment after 8 weeks will be treated with vedolizumab alone fo... Read More
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative colitis (UC). Another aim is to learn about treatment with Vedolizumab alone after the double treatment.
All participants will receive vedolizumab together with tofacitinib for 8 weeks and will be checked for response. Participants who show a response to the treatment after 8 weeks will be treated with vedolizumab alone for an additional 44 weeks.
Each participant will be followed up for at least 26 weeks after the last dose of vedolizumab. Read Less
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
07/24/2025
Locations: Digestive Health Specialsits, Dothan, Alabama +49 locations
Digestive Health Specialsits, Dothan, Alabama
GI Alliance Sun City, Sun City, Arizona
Cedars-Sinai Medical Center, Los Angeles, California
Hoag Hospital Newport Beach, Newport Beach, California
Endoscopic Research Inc, Orlando, Florida
Alliance Clinical Research of Tampa, LLC, Tampa, Florida
Gastroenterology Consultants, P.C., Roswell, Georgia
University of Chicago Medicine, Chicago, Illinois
GI Alliance - Illinois Gastroenterology Group - Glenview, Glenview, Illinois
GI Alliance - Illinois Gastroenterology Group LLC - Gurnee, Gurnee, Illinois
University of Kansas Medical Center, Kansas City, Kansas
University of Louisville, Louisville, Kentucky
GI Alliance, Metairie, Louisiana
Tulane University, New Orleans, Louisiana
Capital Digestive Care - MGG Group - Chevy Chase Clinical Research, Chevy Chase, Maryland
Huron Gastroenterology Associates, P.C., Ypsilanti, Michigan
MNGI Digestive Health, PA, Plymouth, Minnesota
Mid-America Gastro-Intestinal Consultants, Kansas City, Missouri
BVL Clinical Research, Liberty, Missouri
Washington University School of Medicine, Saint Louis, Missouri
NYU Langone Health, New York, New York
Weill Cornell Medical College- New York Presbyterian Hospital, New York, New York
Digestive Health Partners - Asheville Gastroenterology Associate, Asheville, North Carolina
University of North Carolina, Chapel Hill, North Carolina
University of Cincinnati, Cincinnati, Ohio
Ohio Gastroenterology group, Inc., Columbus, Ohio
Gastro Intestinal Research Institute of Northern Ohio, LLC., Westlake, Ohio
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
Allegheny Health Network, Wexford, Pennsylvania
University Gastroenterology, Providence, Rhode Island
Rapid City Medical Center, LLP, Rapid City, South Dakota
GI Alliance - Digestive Health Associates of Texas, Dallas, Texas
The University of Texas Health Science Center at Houston, Houston, Texas
GI Alliance - Mansfield, Mansfield, Texas
Gastroenterology Research of San Antonio, LLC, San Antonio, Texas
Texas Digestive Disease Consultants (TDDC), Southlake, Southlake, Texas
Tyler Research Institute, LLC, Tyler, Texas
GI Alliance - Webster, Webster, Texas
University of Utah Health, Salt Lake City, Utah
Washington Gastroenterology- GIA, Bellevue, Washington
Washington Gastroenterology- GIA, Tacoma, Washington
Barrie GI Associates Inc., Barrie, Ontario
London Health Sciences Centre, London, Ontario
West GTA Endoscopy Inc., Mississauga, Ontario
Viable Clinical Research - North Bay, North Bay, Ontario
Toronto Immune and Digestive Health Institute Inc. (TIDHI), North York, Ontario
ABP Research Services Corp., Oakville, Ontario
Taunton Surgical Centre, Oshawa, Ontario
Toronto Digestive Disease Associates (TDDA) Specialty Research, Vaughan, Ontario
McGill University Health Centre Montreal General Hospital, Montreal, Quebec
Conditions: Ulcerative Colitis
A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)
Recruiting
The purpose of this study is to evaluate the efficacy and safety of repotrectinib and crizotinib in participants with locally advanced or metastatic TKI-naïve ROS1-positive non-small cell lung cancer (NSCLC).
The purpose of this study is to evaluate the efficacy and safety of repotrectinib and crizotinib in participants with locally advanced or metastatic TKI-naïve ROS1-positive non-small cell lung cancer (NSCLC). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/24/2025
Locations: Local Institution - 0136, Augusta, Georgia +143 locations
Local Institution - 0136, Augusta, Georgia
Local Institution - 0221, Des Moines, Iowa
Massachusetts General Hospital, Boston, Massachusetts
Beth Israel Deaconess Medical Center, Boston, Massachusetts
Local Institution - 0217, Brooklyn, New York
Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola, New York
Laura and Isaac Perlmutter Cancer Center, New York, New York
Local Institution - 0127, Syracuse, New York
Local Institution - 0214, Tacoma, Washington
Local Institution - 0061, Milwaukee, Wisconsin
Local Institution - 0092, Ciudad autónoma de Buenos Aires, Buenos Aires
Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Buenos Aires
Local Institution - 0091, ABB, Ciudad Autónoma De Buenos Aires
Local Institution - 0106, Buenos Aires, Not set
Local Institution - 0207, Buenos Aires, Not set
Instituto Oncológico de Córdoba, Córdoba, Not set
Local Institution - 0041, Wien, Not set
Hospital Luxemburgo, Belo Horizonte, Minas Gerais
Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa, Porto Alegre, Rio Grande Do Sul
Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul
Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, São Paulo
Hospital Sírio Libanês, Sao Paulo, São Paulo
Hospital Paulistano, Sao Paulo, São Paulo
Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo
Hospital São Lucas de Copacabana, Rio de Janeiro, Not set
Centro de Tratamento de Tumores Botafogo para Oncoclinicas Rio de Janeiro SA, Rio de Janeiro, Not set
Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo, Not set
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo, Not set
Local Institution - 0002, Toronto, Ontario
Local Institution - 0123, Trois-Rivières, Quebec
Fundacion Arturo Lopez Perez (FALP), Santiago, Región Metropolitana De Santiago
Oncocentro Apys, Viña del Mar, Valparaíso
Local Institution - 0168, Beijing, Beijing
Local Institution - 0185, Chongqing, Chongqing
Local Institution - 0192, Fuzhou, Fujian
Local Institution - 0169, Xiamen, Fujian
Local Institution - 0180, Guangzhou, Guangdong
Local Institution - 0194, Nanning, Guangxi
Local Institution - 0171, Harbin, Heilongjiang
Local Institution - 0166, Zhengzhou, Henan
Local Institution - 0181, Wuhan Shi, Hubei
Local Institution - 0203, Wuhan, Hubei
Local Institution - 0184, Changsha, Hunan
Local Institution - 0165, Changsha, Hunan
Local Institution - 0193, Nanjing, Jiangsu
Local Institution - 0202, Nanchang, Jiangxi
Local Institution - 0178, Changchun, Jilin
Local Institution - 0183, Xi'an, Shaanxi
Local Institution - 0186, Jinan, Shandong
Local Institution - 0205, Linyi, Shandong
Local Institution - 0164, Shanghai, Shanghai
Local Institution - 0179, Shanghai, Shanghai
Local Institution - 0170, Chengdu, Sichuan
Local Institution - 0177, Chengdu, Sichuan
Local Institution - 0204, Kunming, Yunnan
Local Institution - 0206, Hangzhou, Zhejiang
Local Institution - 0175, Hangzhou, Zhejiang
Nouvel Hôpital Civil (NHC), Strasbourg, Alsace
CHU Bordeaux Haut-Leveque, Pessac, Aquitaine
Centre Georges François Leclerc, Dijon, Côte-d'Or
CHU Charles Nicolle, Rouen, Haute-Normandie
Chu Grenoble Alpes, La Tronche, Isère
Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes, Saint-Herblain, Loire-Atlantique
Centre Hospitalier Lyon Sud, Pierre-Bénite, Rhône
Hopitaux Universitaires Paris Centre-Hopital Cochin, Paris, Not set
Klinikum Esslingen, Esslingen, Baden-Württemberg
Klinikum Würzburg Mitte, Wuerzburg, Bayern
Pius Hospital Oldenburg, Oldenburg, Niedersachsen
Evangelische Lungenklinik Berlin, Berlin, Not set
Local Institution - 0035, Dresden, Not set
Asklepios Klinik Gauting GmbH, Gauting, Not set
Lungenfachklinik Immenhausen, Immenhausen, Not set
Universitaetsklinikum Koeln, Köln, Not set
Marienhaus Klinikum Mainz, Mainz, Not set
University Hospital of Patras, Patras, Achaḯa
Thoracic General Hospital of Athens "I Sotiria", Athens, Attikí
Attikon General University Hospital, Chaidari, Attikí
"Theagenio" Cancer Hospital of Thessaloniki, Thessaloniki, Kentrikí Makedonía
Országos Korányi Pulmonológiai Intézet, Budapest, Not set
All India Institute of Medical Sciences, New Delhi, Delhi
Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, Delhi
Hemato Oncology Clinic, Ahmedabad, Gujarat
HCG Aastha Cancer Centre, Ahmedabad, Gujarat
Local Institution - 0117, Gurgaon, Haryana
Artemis hospital, Gurugram, Haryana
Manipal Hospitals, Bengaluru, Karnataka
Local Institution - 0219, Thiruvananthapuram, Kerala
Local Institution - 0065, Mumbai, Maharashtra
Local Institution - 0048, Mumbai, Maharashtra
Grant Medical Foundation - Ruby Hall Clinic, Pune, Maharashtra
Sahyadri Super Speciality Hospital, Pune, Maharashtra
Local Institution - 0220, Hyderabad, Telangana
Cro-Irccs, Aviano, Friuli-Venezia Giulia
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia
Fondazione IRCCS San Gerardo dei Tintori, Monza, Lombardia
A.O.R.N. Ospedale dei Colli - Monaldi V., Naples, Napoli
Istituto Nazionale Tumori Regina Elena, Rome, Roma
Nagoya University Hospital, Nagoya, Aichi
National Cancer Center Hospital East, Kashiwa, Chiba
National Hospital Organization Shikoku Cancer Center, Matsuyama-shi, Ehime
Hokkaido University Hospital, Sapporo, Hokkaido
Kanagawa cancer center, Yokohama, Kanagawa
Sendai Kosei Hospital, Sendai, Miyagi
Tokyo Metropolitan Komagome Hospital, Bunkyo ku, Tokyo
Tottori University Hospital, Yonago, Tottori
National Hospital Organization Kyushu Cancer Center, Fukuoka, Not set
Osaka City General Hospital, Osaka, Not set
Osaka International Cancer Institute, Osaka, Not set
Tokyo Metropolitan Police Hospital, Tokyo, Not set
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do [Chungbuk]
Seoul National University Bundang Hospital, Seongnam, Kyǒnggi-do
Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul]
Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]
Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]
Local Institution - 0223, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur
Local Institution - 0237, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur
Local Institution - 0222, Lembah Pantai, Wilayah Persekutuan Kuala Lumpur
Local Institution - 0226, Lembah Pantai, Wilayah Persekutuan Kuala Lumpur
Local Institution - 0224, Putrajaya, Wilayah Persekutuan Kuala Lumpur
Amsterdam UMC, locatie VUmc, Amsterdam, Noord-Holland
Local Institution - 0215, Groningen, Not set
Local Institution - 0187, Lublin, Lubelskie
Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie, Olsztyn, Warmińsko-mazurskie
SC Memorial Healthcare International SRL, Bucharest, București
Institutul Oncologic Bucuresti, Bucharest, București
Centrul de Oncologie "Sfântul Nectarie", Craiova, Dolj
Institutul Oncologic Cluj, Cluj, Not set
S.C. Centrul de Oncologie Euroclinic S.R.L., Iași, Not set
CHUAC-Hospital Teresa Herrera, A Coruña, A Coruña [La Coruña]
CHUS - Hospital Clinico Universitario, Santiago de Compostela, A Coruña [La Coruña]
Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]
Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad De
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Comunidad De
H.R.U Málaga - Hospital General, Málaga, Not set
Hospital Universitario Virgen Del Rocio, Sevilla, Not set
Hospital Universitari i Politecnic La Fe, València, Not set
Kantonspital Baden, Baden, Aargau
Ankara Bilkent Şehir Hastanesi, Yenimahalle, Ankara
Adana Medical Park Seyhan Hastanesi, Adana, Not set
Sbü Gülhane Eğitim Ve Araştirma Hastanesi, Ankara, Not set
Medipol Mega Universite Hastanesi, Istanbul, Not set
T.C. Saglik Bakanligi Turkiye Kamu Hastaneleri Kurumu - Bakirkoy Dr. Sadi Konuk Egitim ve Arastirma Hastanesi, Istanbul, Not set
VM Medical Park Pendik Hospital, Istanbul, Not set
Sakarya Training and Research Hospital, Sakarya, Not set
Conditions: Carcinoma, Non-Small-Cell Lung
International CRDS Registry
Recruiting
Calcium Release Deficiency Syndrome (CRDS) is a newly discovered genetic arrhythmia syndrome that confers a risk of life-threatening arrhythmias secondary to RYR2 loss-of-function. The International CRDS registry has been designed to facilitate large-scale evaluation of CRDS, including its phenotypic spectrum, approaches to risk stratification, and optimal treatment strategies.
Calcium Release Deficiency Syndrome (CRDS) is a newly discovered genetic arrhythmia syndrome that confers a risk of life-threatening arrhythmias secondary to RYR2 loss-of-function. The International CRDS registry has been designed to facilitate large-scale evaluation of CRDS, including its phenotypic spectrum, approaches to risk stratification, and optimal treatment strategies. Read Less
Gender:
ALL
Ages:
All
Trial Updated:
07/24/2025
Locations: University of California, San Francisco, California +7 locations
University of California, San Francisco, California
Garvan Institute of Medical Research, Darlinghurst, New South Wales
Universitair Ziekenhuis Brussel, Brussels, Not set
Hamilton General Hospital, Hamilton, Ontario
London Health Sciences Centre - University Hospital, London, Ontario
Montréal Heart Institute, Montréal, Quebec
Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval, Québec City, Quebec
Shaare Zedek Medical Center, Jerusalem, Not set
Conditions: Calcium Release Deficiency Syndrome
EXtubation Related Complications - the EXTUBE Study (EXTUBE)
Recruiting
EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU).
EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/24/2025
Locations: Oregon Health & Science University, Portland, Oregon +2 locations
Oregon Health & Science University, Portland, Oregon
Mount Sinai Hospital, Toronto, Ontario
University Health Network - Toronto General Hospital, Toronto, Ontario
Conditions: Extubation
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
Recruiting
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight. Read Less
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
07/24/2025
Locations: Alliance for Multispecialty Research Mobile, Mobile, Alabama +184 locations
Alliance for Multispecialty Research Mobile, Mobile, Alabama
Gilbert Center for Family Medicine, Gilbert, Arizona
Desert Clinical Research, Mesa, Arizona
Avacare Foothills Research Center, Phoenix, Arizona
San Fernando Valley Health Institute, Canoga Park, California
Core Healthcare Group, Cerritos, California
Velocity Clinical Research Chula Vista, Chula Vista, California
Headlands Research California, Escondido, California
Paradigm Clinical Research, Modesto, California
Flourish Research, Northridge, California
University of California Irvine, Orange, California
Empire Clinical Research, Pomona, California
Infinity Clinical Trials, San Diego, California
Greenwich Clinical Trials, Riverside, Connecticut
Indago Research and Health Center, Hialeah, Florida
San Marcus Research Clinic Inc, Miami Lakes, Florida
Optimus U Corporation, Miami, Florida
New Horizon Research Center, Miami, Florida
Florida Institute for Clinical Research, Orlando, Florida
Encore Medical Research of Weston LLC, Weston, Florida
Conquest Research - Winter Park, Winter Park, Florida
Alliance For Multispecialty Research - Oak Brook, Oak Brook, Illinois
Alliance for Multispecialty Research, LLC - Park Ridge, Park Ridge, Illinois
Endeavor Health Medical Group - Endocrinology and Diabetes- Skokie, Skokie, Illinois
Indiana Medical Research Institute, Merrillville, Indiana
Iowa Diabetes Research, West Des Moines, Iowa
Alliance for Multispecialty Research Newton, Newton, Kansas
Alliance for Multispecialty Research LLC, Wichita, Kansas
Advanced Internal Medicine, Paducah, Kentucky
Ima Clinical Research- Monroe, Monroe, Louisiana
Annapolis Internal Medicine, LLC, Annapolis, Maryland
Brigham and Womens Hospital, Boston, Massachusetts
International Diabetes Center - HealthPartners Institute, Minneapolis, Minnesota
Alliance for Multispecialty Research - Kansas City, Kansas City, Missouri
Palm Research Center Inc, Las Vegas, Nevada
Vector Clinical Trials, Sparks, Nevada
Premier Research, Trenton, New Jersey
Albany Medical College, Albany, New York
Asheville Clinical Research, Asheville, North Carolina
Physicians East, Greenville, North Carolina
Carteret Medical Group, Morehead City, North Carolina
West Clinical Research, Morehead City, North Carolina
Velocity Clinical Research - Cincinnati, Blue Ash, Ohio
Velocity Clinical Research - Springdale, Cincinnati, Ohio
Velocity Clinical Research - Providence, East Greenwich, Rhode Island
Medical Care LLC, Elizabethton, Tennessee
Elligo Clinical Research Center, Austin, Texas
Osvaldo A Brusco MD PA, Corpus Christi, Texas
Cedar Health Research, LLC, Dallas, Texas
Soma Clinical Trials, LLC, Denison, Texas
Cedar Health Research, LLC, Euless, Texas
Juno Research LLC, Houston, Texas
Juno Research LLC, Houston, Texas
Tekton Research, McKinney, Texas
Northeast Clinical Research of San Antonio LLC, San Antonio, Texas
Alliance for Multispecialty Research - Layton, Layton, Utah
Manassas Clinical Research Center Inc, Manassas, Virginia
VA Puget Sound Healthcare System, Seattle, Washington
Ima Clinical Research - West Virginia, Morgantown, West Virginia
Centro Medico Viamonte, Caba, Buenos Aires
Cedic Centro de Investigacion Clinica, Caba, Buenos Aires
Cemedic Centro de Especialidades Medicas, Caba, Buenos Aires
Maffei Centro Medico, Caba, Buenos Aires
Cinme - Centro de Investigaciones Metabolicas, Ciudad Autonoma de Buenos Aires, Buenos Aires
Ciprec Centro de Investigacion y Prevencion Cardiovascular, Ciudad Autonoma de Buenos Aires, Buenos Aires
Ambulatory for specialized outpatient medical aid in endocrinology-Dr Albena Dinkova EOOD, Pleven, Not set
Diagnostic - Consultative Center XX - Sofia EOOD, Sofia, Not set
Acibadem City Clinic University Multiprofile Hospital for Active Treatment Tokuda EAD, Sofia, Not set
University Multiprofile Hospital for Active Treatment Sofiamed OOD, Sofia, Not set
Prevencia-2000-Medical center for outpatient medical aid OOD, Stara Zagora, Not set
Medical Center Berbatov EOOD, Yambol, Not set
tlc Diabetes and Endocrinology, Surrey, British Columbia
Chronic Disease Innovation Centre, Winnipeg, Manitoba
Nova Scotia Health Authority, Queen Elizabeth ii Health Sciences Centre, Halifax, Nova Scotia
Centricity Research Brampton, Brampton, Ontario
Aggarwal and Associates Ltd, Brampton, Ontario
Centricity Research Vaughan, Concord, Ontario
Winterberry Family Medicine, Hamilton, Ontario
Premier Clinical Trial Network, Hamilton, Ontario
Milestone Research, London, Ontario
Centricity Research Ottawa LMC, Nepean, Ontario
Your Research Network Inc., Niagara Falls, Ontario
North York Diagnostic and Cardiac Centre, North York, Ontario
Bluewater Clinical Research Group Incorporated, Sarnia, Ontario
Albion Finch Medical Centre, Toronto, Ontario
Centricity Research Quebec City, Levis, Quebec
Institut de recherches cliniques de Montreal, Montreal, Quebec
Centre Medical Acadie, Montreal, Quebec
Centricity Research Pointe-Claire, Pointe-Claire, Quebec
Diex Recherche Trois Rivieres, Trois-Rivieres, Quebec
Fakultni nemocnice Brno, Brno, Not set
CCR Ostrava sro, Ostrava, Not set
Diahelp sro, Pardubice, Not set
Pratia Pardubice as, Pardubice, Not set
Fakultni nemocnice Kralovske Vinohrady, Praha 10, Not set
Institut klinicke a experimentalni mediciny, Praha 4, Not set
Milan Kvapil sro, Praha 4, Not set
Restrial sro, Praha 8, Not set
Endokrinologie Cerny Most sro, Praha 9, Not set
Vseobecna fakultni nemocnice v Praze, Praha, Not set
Milan Kvapil sro, Pribram VIII, Not set
Universitatsklinikum Aachen, Aachen, Not set
Universitaets-Herzzentrum Freiburg - Bad Krozingen, Bad Krozingen, Not set
Diabetespraxis Bad Mergentheim, Bad Mergentheim, Not set
Universitaetsklinikum der Ruhr-Universitaet Bochum, Bad Oeynhausen, Not set
Charite - Universitaetsmedizin Berlin, Campus Mitte, Berlin, Not set
Velocity Clinical Research GmbH, Berlin, Not set
Diabetespraxis Dr. Hermann Braun, Berlin, Not set
Mvz am Bahnhof Spandau, Berlin, Not set
Zentrum fuer Klinische Studien Suedbrandenburg GmbH, Elsterwerda, Not set
InnoDiab Forschung, Essen, Not set
Schwerpunktpraxis fuer Diabetes, Gefaess- & Ernaehrungsmedizin, Falkensee, Not set
Diabeteszentrum Hamburg West, Hamburg, Not set
Endokrinologikum Hamburg, Hamburg, Not set
Diabetologische Schwerpunktpraxis Hohenmoelsen, Hohenmoelsen, Not set
Universitaetsklinikum Leipzig, Leipzig, Not set
AmBeNet GmbH, Leipzig, Not set
Kardiologische Praxis Doktor Jens Taggeselle, Markkleeberg, Not set
Centrum für Diagnostik und Gesundheit, Muenchen, Not set
Zentrum fuer Diabtes und Gefaesskrankheiten im Franziskus Carré Muenster, Muenster, Not set
Red-Institut GmbH, Oldenburg, Not set
Lausmed Kft, Baja, Not set
DRC Gyogyszervizsgalo Kozpont Kft, Balatonfured, Not set
Clinexpert Kft, Budapest, Not set
Obudai Egeszsegugyi Centrum Kft, Budapest, Not set
ClinDiab Kft, Budapest, Not set
MED-TIMA Kft, Budapest, Not set
Borvo Clinic Kft, Debrecen, Not set
Debreceni Egyetem Klinikai Kozpont, Debrecen, Not set
Komaromi Selye Janos Korhaz, Komarom, Not set
Borbanya Praxis Egeszsegugyi Kft, Nyiregyhaza, Not set
Vas Varmegyei Markusovszky Egyetemi Oktatokorhaz, Szombathely, Not set
IRCCS Azienda Ospedaliero Universitaria di Bologna Policlinico di Sant Orsola, Bologna, Not set
Universita degli Studi Gabriele D Annunzio di Chieti e Pescara, Chieti, Not set
Azienda Ospedaliero Universitaria Careggi, Firenze, Not set
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milano, Not set
IRCCS Centro Cardiologico Monzino, Milano, Not set
Azienda Socio Sanitaria Territoriale Fatebenefratelli Sacco, Milano, Not set
Mikannohana Clinic, Diabetes, Endocrinology and Metabolism, Matsuyama-shi, Ehime
Morizono Medical Clinic, Kitakyusyu-shi, Fukuoka
Mazda Hospital of Mazda Motor Corporation, Aki-gun, Hiroshima
Nakamoto Medical Clinic, Mito-shi, Ibaraki
Nakakinen Clinic, Naka-shi, Ibaraki
Ohishi Naika Clinic, Tsuchiura-shi, Ibaraki
Morinaga Ueno Clinic, Kumamoto-shi, Kumamoto
Shiraiwa Medical Clinic, Kashiwara-shi, Osaka
Suruga Clinic, Shizuoka-shi, Shizuoka
Yutenji Medical Clinic, Meguro-ku, Tokyo
Medical Corporation Ouitsukai Kanno Naika, Mitaka-shi, Tokyo
Korea University Ansan Hospital, Ansan-si, Gyeonggi-do, Not set
Yeungnam University Medical Center, Daegu, Not set
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Not set
Korea University Anam Hospital, Seoul, Not set
Seoul National University Hospital, Seoul, Not set
Kangbuk Samsung Hospital, Seoul, Not set
Severance Hospital Yonsei University Health System, Seoul, Not set
KyungHee University Gangdong Hospital, Seoul, Not set
Asan Medical Center, Seoul, Not set
The Catholic University of Korea Seoul St Marys Hospital, Seoul, Not set
Hallym University Kangnam Sacred Heart Hospital, Seoul, Not set
Yonsei University Wonju Severance Christian Hospital, Wonju-si, Gangwon-do, Not set
Salvia-Lekston i Madej Spolka Jawna, Katowice, Not set
Centrum Terapii Wspolczesnej J M Jasnorzewska Spolka Komandytowo Akcyjna, Lodz, Not set
Clinical Best Solutions Sp zoo Spolka Komandytowa Gabinet Lekarski, Lublin, Not set
Ekamed Spolka z Ograniczona Odpowiedzialnoscia, Lublin, Not set
Medicome Spolka z Ograniczona Odpowiedzialnoscia, Oswiecim, Not set
Velocity Nova Sp zoo Velocity Pulawy, Pulawy, Not set
NZOZ Przychodnia Specjalistyczna A Wittek H Rudzki spolka jawna, Ruda Slaska, Not set
Velocity Nova Sp zoo Velocity Staszow, Staszow, Not set
Tomasz Blicharski Lubelskie Centrum Diagnostyczne, Swidnik, Not set
Nbr Polska Tomasz Klodawski, Warszawa, Not set
Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych i Administracji, Warszawa, Not set
Wromedica I Bielicka A Strzalkowska SC, Wroclaw, Not set
Latin Clinical Trial Center, San Juan, Not set
Ormeau Clinical Trials Ltd, Belfast, Not set
FutureMeds Birmingham, Birmingham, Not set
Layton Medical Centre, Blackpool, Not set
Waterloo Medical Centre, Blackpool, Not set
Southmead Hospital, Bristol, Not set
Staploe Medical Centre, Ely, Not set
FutureMeds Glasgow, Glasgow, Not set
Hull Royal Infirmary, Hull, Not set
NIHR Leicestershire & Northamptonshire Commercial Research Delivery Centre, Leicester, Not set
Aintree University Hospital, Liverpool, Not set
Clifton Medical Centre, Rotherham, Not set
Conditions: Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
A Phase 2 Study of AMG 193 in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
Recruiting
The main objective of the study is to characterize safety and efficacy of 2 dose levels of AMG 193 by investigator, and to evaluate AMG 193 monotherapy efficacy by Blinded Independent Central Review (BICR).
The main objective of the study is to characterize safety and efficacy of 2 dose levels of AMG 193 by investigator, and to evaluate AMG 193 monotherapy efficacy by Blinded Independent Central Review (BICR). Read Less
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
07/24/2025
Locations: City of Hope National Medical Center, Duarte, California +80 locations
City of Hope National Medical Center, Duarte, California
City of Hope Orange County Lennar Foundation Cancer Center, Duarte, California
Cedars-Sinai Medical Center, Los Angeles, California
Valkyrie Clinical Trials, Los Angeles, California
University of California Los Angeles, Los Angeles, California
Rocky Mountain Cancer Centers, Denver, Colorado
Eastern Connecticut Hematology and Oncology Associates, Norwich, Connecticut
Medstar Georgetown University Hospital, Washington, District of Columbia
Our Lady of the Lake Cancer Institute, Baton Rouge, Louisiana
Trinity Health Saint Joseph Mercy Ann Arbor, Ann Arbor, Michigan
Cancer and Hematology Centers of Western Michigan, Grand Rapids, Michigan
Sarah Cannon Research Institute Oncology Partners, Nashville, Tennessee
United States Oncology Regulatory Affairs Corporate Office, Nashville, Tennessee
Texas Oncology Central/South Texas, Austin, Texas
Mary Crowley Cancer Research, Dallas, Texas
Texas Oncology - Dallas Fort Worth, Dallas, Texas
US Oncology Research Investigational Products Center, Irving, Texas
Texas Oncology Northeast Texas, Tyler, Texas
Virginia Cancer Specialists PC, Fairfax, Virginia
GenesisCare -North Shore Oncology, St Leonards, New South Wales
Calvary Mater Newcastle Hospital, Waratah, New South Wales
Mater Hospital Brisbane, South Brisbane, Queensland
Núcleo de Oncologia da Bahia, Salvador, Bahia
Liga Norte-Riograndense Contra O Cancer, Natal, Rio Grande Do Norte
Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Rio Grande Do Sul
Hospital Nossa Senhora da Conceicao, Porto Alegre, Rio Grande Do Sul
Fundacao Pio 12 Hospital de Amor de Barretos, Barretos, São Paulo
Instituto do Cancer Estado SP Icesp, Sao Paulo, São Paulo
Fundacao Antonio Prudente - Hosp AC Camargo, Sao Paulo, São Paulo
Fund Fac Reg Med Sao Jose Rio Preto, São José do Rio Preto, São Paulo
Instituto de Educacao Pesquisa e Gestao em Saude, Rio de Janeiro, Not set
Centro Paulista de Oncologia, São Paulo, Not set
Princess Margaret Cancer Centre, Toronto, Ontario
McGill University Health Centre Glen Site, Montreal, Quebec
Beijing Cancer Hospital2, Beijing, Beijing
Mengchao Hepatobiliary hospital of Fujian Medical University, Fuzhou, Fujian
Henan Cancer Hospital, Zhengzhou, Henan
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan
Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei
The Second Xiangya Hospital of Central South University, Changsha, Hunan
Jilin Cancer Hospital, Changchun, Jilin
Jinan Central Hospital, Jinan, Shandong
Shanghai East Hospital, Shanghai, Shanghai
West China Hospital Of Sichuan University, Chengdu, Sichuan
The First Affiliated Hospital Zhejiang University School Of Medicine, Hangzhou, Zhejiang
Zhejiang Cancer Hospital, Hangzhou, Zhejiang
Beijing Cancer Hospital, Beijing, Not set
Beijing Chest Hospital, Capital Medical University, Beijing, Not set
Masarykuv onkologicky ustav, Brno, Not set
Fakultni nemocnice Olomouc, Olomouc, Not set
Vseobecna fakultni nemocnice v Praze, Praha 2, Not set
Fakultni Thomayerova nemocnice, Praha 4, Not set
Queen Mary Hospital, The University of Hong Kong, Hong Kong, Not set
Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, New Territories, Not set
Aichi Cancer Center, Nagoya-shi, Aichi
National Cancer Center Hospital East, Kashiwa-shi, Chiba
Shizuoka Cancer Center, Sunto-gun, Shizuoka
National Cancer Center Hospital, Chuo-ku, Tokyo
The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo
Wakayama Medical University Hospital, Wakayama-shi, Wakayama
Cha Bundang Medical Center, Cha University, Seongnam-si, Gyeonggi-do, Not set
Severance Hospital Yonsei University Health System, Seoul, Not set
Ajou University Hospital, Suwon-si Gyeonggi-do, Not set
The Catholic University of Korea St Vincents Hospital, Suwon-si, Gyeonggi-do, Not set
Nederlands Kanker Instituut Antoni van Leeuwenhoekziekenhuis, Amsterdam, Not set
Sint Jansdal Ziekenhuis, Harderwijk, Not set
Erasmus Medisch Centrum, Rotterdam, Not set
Unidade Local de Saude de Braga, EPE, Braga, Not set
Fundacao Champalimaud, Lisboa, Not set
Hospital Cuf porto, Porto, Not set
Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE, Porto, Not set
National University Hospital, Singapore, Not set
National Cancer Centre Singapore, Singapore, Not set
Taichung Veterans General Hospital, Taichung, Not set
National Cheng Kung University Hospital, Tainan, Not set
National Taiwan University Hospital, Taipei, Not set
Adana Sehir Egitim ve Arastirma Hastanesi, Adana, Not set
Gazi Universitesi Saglik Arastirma ve Uygulama Merkezi Gazi Hastanesi, Ankara, Not set
Ankara Bilkent Sehir Hastanesi, Ankara, Not set
Memorial Bahcelievler Hastanesi, Istanbul, Not set
Bagcilar Medipol Mega Universite Hastanesi, Istanbul, Not set
Conditions: MTAP-deleted NSCLC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Recruiting
Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in areas of the skin such as under the breasts, under armpits, inner thighs, groin and buttocks. This study will compare lutikizumab versus placebo for the treatment of adult and adolescent participants with the signs and symptoms of moderate to severe HS .
Lutikizumab is an investigational drug being developed for the treatment of HS. During Period 1 o... Read More
Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in areas of the skin such as under the breasts, under armpits, inner thighs, groin and buttocks. This study will compare lutikizumab versus placebo for the treatment of adult and adolescent participants with the signs and symptoms of moderate to severe HS .
Lutikizumab is an investigational drug being developed for the treatment of HS. During Period 1 of the study, participants will placed in 1 of 2 groups called treatment arms. There is a 1 in 2 chance that participants will be assigned to placebo. Around 1280 adult and adolescent participants with moderate to severe HS will be enrolled in the study at approximately 275 sites world wide. During Period 2, participants that were part of the lutikizumab treatment arm in Period 1 will be re-randomized to 1 of 2 lutikizumab treatment arms. Participants that were part of the Placebo arm in Period 1 will start Period 2 with an initiation of lutikizumab followed by a re-randomization to 1 of 2 lutikizumab treatment arms.
In Period 1, participants will receive subcutaneous injections of lutikizumab or placebo every week for 16 weeks. In Period 2, participants that were randomized to lutikizumab in Period 1 will receive subcutaneous injections of lutikizumab every week or every other week for 36-weeks. Participants that were randomized to the placebo arm in Period 1 will receive subcutaneous injections of lutikizumab every week for 16 weeks, then either every week or every other week for 20 weeks.
Period 3 is the Long Term Extentsion (LTE) and through Week 68, participants will continue to receive lutikizumab SC using the same assigned dosing regimen from the end of Period 2 for 16 weeks followed by open-label lutikizumab EOW for 140 weeks.
Participants in the US that complete Periods 1 \& 2 will have the option to enroll in a 156-week open-label Sub-Study that will assess the long term safety and efficacy of lutikizumab in a prefilled pen.
There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires and diaries. Read Less
Gender:
ALL
Ages:
12 years and above
Trial Updated:
07/24/2025
Locations: Cahaba Dermatology & Skin Health Center /ID# 263795, Birmingham, Alabama +239 locations
Cahaba Dermatology & Skin Health Center /ID# 263795, Birmingham, Alabama
Medical Dermatology Specialists /ID# 263394, Phoenix, Arizona
Dermatology Trial Associates /ID# 264587, Bryant, Arkansas
Arkansas Research Trials /ID# 263901, North Little Rock, Arkansas
Private Practice - Dr. Tooraj Raoof /ID# 263756, Encino, California
Dermatology Research Associates - Los Angeles /ID# 263765, Los Angeles, California
Stanford University School of Medicine - Redwood City /ID# 263711, Redwood City, California
Integrative Skin Science and Research /ID# 264600, Sacramento, California
Clinical Trials Research Institute /ID# 263743, Thousand Oaks, California
Clearlyderm Dermatology - West Boca /ID# 265023, Boca Raton, Florida
Apex Clinical Trials /ID# 263815, Brandon, Florida
TrueBlue Clinical Research /ID# 265041, Brandon, Florida
Skin Care Research - Hollywood /ID# 263805, Hollywood, Florida
GSI Clinical Research, LLC /ID# 263827, Margate, Florida
Sullivan Dermatology /ID# 263511, Miami, Florida
Renstar Medical Research - Ocala - Northeast 1st Avenue /ID# 263842, Ocala, Florida
Skin Care Research - Tampa /ID# 263819, Tampa, Florida
Advanced Clinical Research Institute /ID# 263808, Tampa, Florida
University of South Florida /ID# 269624, Tampa, Florida
Alliance Clinical Research of Tampa /ID# 264594, Tampa, Florida
Centricity Research Columbus Dermatology /ID# 266530, Columbus, Georgia
Cleaver Medical Group Dermatology /ID# 263845, Dawsonville, Georgia
Treasure Valley Medical Research /ID# 263671, Boise, Idaho
Northwestern University Feinberg School of Medicine /ID# 265007, Chicago, Illinois
Arlington Dermatology /ID# 263410, Rolling Meadows, Illinois
Dawes Fretzin, LLC /ID# 264601, Indianapolis, Indiana
Dermatology Partners of Leawood /ID# 263533, Leawood, Kansas
Equity Medical, LLC /ID# 268590, Bowling Green, Kentucky
Dermatology Specialists Research (DS Research) - Kentucky /ID# 263343, Louisville, Kentucky
Tulane University School of Medicine /ID# 263899, New Orleans, Louisiana
Beth Israel Deaconess Medical Center /ID# 263709, Boston, Massachusetts
Hamzavi Dermatology - Canton /ID# 263538, Canton, Michigan
Michigan Center for Medical Research /ID# 263547, Clarkston, Michigan
Dermatology and Skin Center of Lees Summit /ID# 263567, Lee's Summit, Missouri
MediSearch Clinical Trials /ID# 263582, Saint Joseph, Missouri
Vivida Dermatology- Flamingo /ID# 263716, Las Vegas, Nevada
Dartmouth Hitchcock Medical Center - Old Etna Road /ID# 263713, Lebanon, New Hampshire
ActivMed Practice and Research, LLC /ID# 263387, Portsmouth, New Hampshire
Mount Sinai Doctors - Dermatology /ID# 264602, New York, New York
Atrium Health Wake Forest Baptist Medical Center /ID# 264507, Winston-Salem, North Carolina
Dermatology of Greater Columbus /ID# 263497, Bexley, Ohio
University Hospitals Cleveland Medical Center /ID# 263600, Cleveland, Ohio
Ohio State Officenter Gahanna /ID# 263598, Gahanna, Ohio
Dermatologists of Southwest Ohio - Mason /ID# 263588, Mason, Ohio
Apex Clinical Research Center /ID# 272787, Mayfield Heights, Ohio
Dermatology Partners /ID# 264999, Philadelphia, Pennsylvania
University of Pittsburgh Medical Center /ID# 264590, Pittsburgh, Pennsylvania
Clinical Research Center of the Carolinas /ID# 263407, Charleston, South Carolina
Medical University of South Carolina /ID# 263890, Charleston, South Carolina
ADCS - Spartanburg /ID# 267207, Spartanburg, South Carolina
Arlington Research Center, Inc /ID# 263895, Arlington, Texas
Bellaire Dermatology Associates /ID# 263850, Bellaire, Texas
Studies in Dermatology LLC /ID# 263399, Cypress, Texas
Reveal Research Institute - Dallas /ID# 267233, Dallas, Texas
Center for Clinical Studies - Houston - Binz Street /ID# 263378, Houston, Texas
Texas Dermatology Research Center /ID# 264488, Plano, Texas
Texas Dermatology and Laser Specialists /ID# 263778, San Antonio, Texas
Dermatology Associates of Tyler /ID# 265002, Tyler, Texas
University of Utah /ID# 263818, Murray, Utah
Virginia Clinical Research /ID# 264553, Norfolk, Virginia
Dermatology Specialists of Spokane /ID# 264499, Spokane, Washington
Paratus Clinical Research Woden /ID# 263125, Phillip, Australian Capital Territory
Momentum Clinical Research /ID# 263192, Darlinghurst, New South Wales
Premier Dermatology /ID# 263124, Kogarah, New South Wales
Veracity Clinical Research /ID# 263126, Woolloongabba, Queensland
Sinclair Dermatology - Melbourne /ID# 263121, East Melbourne, Victoria
Medizinische Universitaet Graz /ID# 263306, Graz, Steiermark
Medizinische Universitaet Wien /ID# 264043, Wien, Not set
Universite Libre de Bruxelles - Hopital Erasme /ID# 263097, Anderlecht, Bruxelles-Capitale
Cliniques Universitaires UCL Saint-Luc /ID# 263096, Bruxelles, Bruxelles-Capitale
Universitair Ziekenhuis Brussel /ID# 263101, Jette, Bruxelles-Capitale
Grand Hôpital de Charleroi - Les Viviers /ID# 263100, Charleroi, Hainaut
CHU de Liège /ID# 263095, Liège, Liege
UZ Gent /ID# 263099, Gent, Oost-Vlaanderen
Universitair Ziekenhuis Leuven /ID# 263098, Leuven, Vlaams-Brabant
Klinicki centar Banja Luka /ID# 265905, Banja Luka, Republika Srpska
Klinicki centar Banja Luka /ID# 265909, Banja Luka, Republika Srpska
Clinical Center University of Sarajevo - Bolnička /ID# 265908, Sarajevo, Not set
University Clinical Center Tuzla /ID# 265906, Tuzla, Not set
Acibadem City Clinic Tokuda Hospital /ID# 263300, Sofiya, Sofia
ASMC-IPSMC-Skin and Venereal Diseases /ID# 262891, Sofiya, Sofia
Medical Center Hera EOOD /ID# 263010, Sofiya, Sofia
Medical Center Cordis /ID# 262894, Pleven, Not set
Diagnostic consultative center Focus-5 /ID# 262893, Sofiya, Not set
UMHAT Professor Stoyan Kirkovich /ID# 262892, Stara Zagora, Not set
Beacon Dermatology Inc /ID# 264262, Calgary, Alberta
Rejuvenation Dermatology - Edmonton Downtown /ID# 265963, Edmonton, Alberta
Stratica Dermatology /ID# 265856, Edmonton, Alberta
Interior Dermatology Centre - Probity - PPDS /ID# 266202, Kelowna, British Columbia
Brunswick Dermatology Center /ID# 264260, Fredericton, New Brunswick
Karma Clinical Trials /ID# 265962, St. John's, Newfoundland and Labrador
Skin Health /ID# 267735, Cobourg, Ontario
Leader Research /ID# 266114, Hamilton, Ontario
DermEffects /ID# 265262, London, Ontario
Derm Care Clinic /ID# 265261, Mississauga, Ontario
York Dermatology Clinic & Research Centre /ID# 265265, Richmond Hill, Ontario
FACET Dermatology /ID# 265267, Toronto, Ontario
Private Practice - Dr. Kim Papp Clinical Research /ID# 265266, Waterloo, Ontario
Centre de Recherche Saint-Louis /ID# 265855, Québec, Quebec
Private Practice - Dr. Angelique Gagne-Henley /ID# 264263, St-Jérôme, Quebec
SkinSense Dermatology /ID# 265964, Saskatoon, Saskatchewan
Diex Recherche Quebec Inc. /ID# 265263, Quebec, Not set
Fundacion Innovacion Cardiovascular /ID# 264844, Independencia, Region Metropolitana De Santiago
Centro Internacional de Estudios Clinicos - CIEC /ID# 266129, Santiago, Region Metropolitana Santiago
Clinica Dermacross /ID# 266127, Vitacura, Region Metropolitana Santiago
Klinicki bolnicki centar Osijek /ID# 265916, Osijek, Osjecko-baranjska Zupanija
Specialty Hospital Medico /ID# 263922, Rijeka, Primorsko-goranska Zupanija
Klinicki Bolnicki Centar Zagreb /ID# 263989, Grad Zagreb, Not set
Fakultní nemocnice Ostrava /ID# 264041, Ostrava, Ostrava-mesto
Karlovarska Krajska Nemocnice - Karlovy Vary /ID# 265354, Karlovy Vary, Not set
Fakultni nemocnice Kralovske Vinohrady /ID# 264040, Praha, Not set
Herlev and Gentofte Hospital /ID# 265839, Hellerup, Hovedstaden
Aarhus Universitetshospital - Skejby /ID# 265657, Aarhus, Midtjylland
Hopital Edouard Herriot /ID# 263456, Lyon, Auvergne-Rhone-Alpes
Centre Hospitalier Universitaire de Saint Etienne - Hopital Nord /ID# 263459, St-Priest-en-Jarez, Loire
Cabinet medical - Le bateau Blanc /ID# 263465, Martigues, Provence-Alpes-Cote-d Azur
Centre Hospitalier Universitaire de Rouen (CHU)- Hopital Charles Nicolle /ID# 263995, Rouen, Seine-Maritime
Groupe Hospitalier Paris Saint-Joseph /ID# 263996, Paris, Not set
Polyclinique Courlancy /ID# 263313, Reims, Not set
Universitaetsklinikum Freiburg /ID# 263659, Freiburg, Baden-Wuerttemberg
Universitaetsklinikum Tuebingen /ID# 271718, Tübingen, Baden-Wuerttemberg
Universitaetsklinikum Erlangen /ID# 263075, Erlangen, Bayern
Beldio Research GmbH /ID# 263074, Memmingen, Bayern
Rosenpark Research /ID# 269202, Darmstadt, Hessen
Fachklinik Bad Bentheim /ID# 263067, Bad Bentheim, Niedersachsen
Katholisches Klinikum Bochum /ID# 262976, Bochum, Nordrhein-Westfalen
Universitaetsklinikum Muenster /ID# 263068, Muenster, Nordrhein-Westfalen
Hautarztpraxis Mortazawi /ID# 271673, Remscheid, Nordrhein-Westfalen
Hautarztpraxis Dr. Kirschner /ID# 263656, Mainz, Rheinland-Pfalz
Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 263076, Berlin, Not set
University General Hospital Attikon /ID# 263413, Athens, Attiki
General Hospital Andreas Syggros /ID# 263417, Athens, Attiki
Hospital of Skin and Venereal Diseases- Thessaloniki /ID# 263416, Thessaloniki, Not set
Papageorgiou General Hospital /ID# 263415, Thessaloniki, Not set
Dermos S.A. /ID# 265857, Guatemala City, Not set
Prosalud /Id# 266586, Guatemala, Not set
Debreceni Egyetem-Klinikai Kozpont /ID# 263423, Debrecen, Hajdu-Bihar
Somogy Varmegyei Kaposi Mor Oktato Korhaz /ID# 263424, Kaposvár, Somogy
Semmelweis Egyetem /ID# 263451, Budapest, Not set
Pécsi Tudományegyetem /ID# 264120, Pécs, Not set
Our Lady of Lourdes Hospital - Drogheda /ID# 265893, Drogheda, Louth
South Infirmary Victoria University Hospital /ID# 265872, Cork, Not set
University College Dublin /ID# 265875, Dublin, Not set
Mater Misericordiae University Hospital /ID# 265914, Dublin, Not set
HaEmek Medical Center /ID# 267297, Afula, Haifa
Rabin Medical Center /ID# 262992, Petah Tikva, HaMerkaz
Galilee Medical Center /ID# 262995, Naharia, HaTsafon
The Chaim Sheba Medical Center /ID# 262993, Ramat Gan, Tel-Aviv
Tel Aviv Sourasky Medical Center /ID# 266581, Tel Aviv, Tel-Aviv
Rambam Health Care Campus /ID# 262994, Haifa, Not set
Hadassah Medical Center-Hebrew University /ID# 262884, Jerusalem, Not set
AZIENDA USL TOSCANA CENTRO - Ospedale Piero Palagi /ID# 263454, Florence, Firenze
IRCCS Istituto Clinico Humanitas /ID# 263503, Rozzano, Lombardia
Azienda Ospedaliera Universitaria Federico II /ID# 263539, Naples, Napoli
Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 263473, Rome, Roma
AOU Policlinico G. Rodolico - San Marco /ID# 263469, Catania, Not set
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico /ID# 263471, Milano, Not set
Nagoya City University Hospital /ID# 263874, Nagoya, Aichi
Fujita Health University Hospital /ID# 265440, Toyoake, Aichi
Takagi Dermatological Clinic /ID# 264810, Obihiro-Shi, Hokkaido
Iwate Medical University Uchimaru Medical Center /ID# 273799, Morioka, Iwate
University Hospital Kyoto Prefectural University of Medicine /ID# 264291, Kyoto-shi, Kyoto
University of the Ryukyus Hospital /ID# 264605, Ginowan-shi, Okinawa
Kindai University Hospital /ID# 264322, Osaka sayama-shi, Osaka
Osaka Metropolitan University Hospital /ID# 265682, Osaka-shi, Osaka
Dokkyo Medical University Saitama Medical Center /ID# 265400, Koshigaya, Saitama
Fukuoka University Hospital /ID# 263991, Fukuoka, Not set
Nihon University Itabashi Hospital /ID# 264661, Tokyo, Not set
Pusan National University Hospital /ID# 271496, Busan, Busan Gwang Yeogsi
SoonChunHyang University Hospital Cheonan /ID# 271320, Cheonan-si, Chungcheongnamdo
Korea University Ansan Hospital /ID# 264227, Ansan-si, Gyeonggido
CHA Bundang Medical Center /ID# 264225, Seongnam, Gyeonggido
Yonsei University Health System Severance Hospital /ID# 271353, Seoul, Seoul Teugbyeolsi
SoonChunHyang University Seoul Hospital /ID# 264224, Seoul, Seoul Teugbyeolsi
Asan Medical Center /ID# 264228, Seoul, Seoul Teugbyeolsi
Hallym University Kangnam Sacred Heart Hospital /ID# 264226, Seoul, Seoul Teugbyeolsi
Cryptex Investigación Clínica /ID# 265271, Mexico City, Distrito Federal
Grupo Clinico CATEI S C /ID# 265276, Guadalajara, Jalisco
Eukarya PharmaSite /ID# 265307, Monterrey, Nuevo Leon
Sociedad de Metabolismo y Corazon S.C. /ID# 265915, Veracruz, Not set
Erasmus Medisch Centrum /ID# 263377, Rotterdam, Zuid-Holland
Greenlane Clinical Centre /ID# 263191, Epsom, Auckland
Clinical Trials New Zealand /ID# 265432, Hamilton, Waikato
Stavanger Universitetssykehus /ID# 265997, Stavanger, Rogaland
Universitetssykehuset I Nord-Norge /ID# 265992, Tromsø, Troms
Oslo University Hospital - Rikshospitalet /ID# 265996, Oslo, Not set
Oftalmika sp. z o.o. /ID# 263087, Bydgoszcz, Kujawsko-pomorskie
DERMED Centrum Medyczne Sp. z o.o /ID# 263147, Lodz, Lodzkie
Santa Sp. z o..o. Santa Familia PTG Lodz /ID# 263181, Lodz, Lodzkie
Centrum Nowoczesnych Terapii 'Dobry Lekarz' sp.z.o.o. /ID# 263146, Krakow, Malopolskie
Klinika Ambroziak Dermatologia /ID# 263173, Warszawa, Mazowieckie
Unidade Local de Saude do Alto Ave, EPE /ID# 265158, Guimaraes, Braga
CUF Descobertas Hospital /ID# 263188, Lisbon, Lisboa
Unidade Local de Saude de Sao Jose, EPE /ID# 265155, Lisboa, Not set
Unidade Local de Saude de Santo Antonio, E.P.E. /ID# 265479, Porto, Not set
Private Practice - Dr. Alma Cruz /ID# 263204, Carolina, Not set
Clinical Research Puerto Rico /ID# 263450, San Juan, Not set
Spitalul Clinic Colentina /ID# 263303, Bucharest, Bucuresti
Private Practice - Dr. Orasan Remus /ID# 263305, Cluj Napoca, Cluj
Centrul Medical Euromed /ID# 263304, Bucharest, Not set
King Abdulaziz Medical City /ID# 266121, Jeddah, Makkah
King Saud University Med City /ID# 266120, Riyadh, Not set
Military Medical Academy /ID# 263257, Belgrade, Beograd
University Clinical Center Serbia /ID# 263256, Belgrade, Beograd
University Clinical Center Kragujevac /ID# 264211, Kragujevac, Sumadijski Okrug
University Clinical Center Vojvodina /ID# 263260, Novi Sad, Not set
National University Hospital /ID# 264673, Singapore, Not set
National Skin Centre /ID# 264680, Singapore, Not set
Univerzitna nemocnica L. Pasteura Kosice /ID# 263907, Košice, Kosicky Kraj
Fakultna nemocnica s poliklinikou Nove Zamky /ID# 265944, Nové Zámky, Nitriansky Kraj
Poliklinika Bezrucova (Cliniq s.r.o.) /ID# 263921, Bratislava, Not set
Fakultna nemocnica Trnava /ID# 263905, Trnava, Not set
University Medical Centre Ljubljana /ID# 265720, Ljubljana, Not set
University Medical Centre Maribor /ID# 265827, Maribor, Not set
Global Clinical Trials /ID# 262839, Pretoria, Gauteng
Life Chatsmed Garden Hospital /ID# 270237, Chatsworth, Kwazulu-Natal
Ahmed Al-Kadi Private Hospital /ID# 262837, Durban, Kwazulu-Natal
Dr Ahmed Ismail Manjra /ID# 262838, Westville, Kwazulu-Natal
Hospital Universitari Parc Tauli /ID# 262942, Sabadell, Barcelona
Hospital Universitario Marqués de Valdecilla /ID# 263039, Santander, Cantabria
Hospital Universitario Virgen de la Victoria /ID# 262941, Málaga, Malaga
Hospital de Manises /ID# 262938, Manises, Valencia
Hospital General Universitario Gregorio Marañón /ID# 262940, Madrid, Not set
Consorci Hospital General Universitario de Valencia /ID# 262944, Valencia, Not set
Karolinska University Hospital Solna /ID# 264530, Solna, Stockholms Lan
Universitetssjukhuset Örebro /ID# 265064, Örebro, Not set
Dermatology & Skin Care Clinic /ID# 264030, Buochs, Nidwalden
Kantonsspital St.Gallen /ID# 264238, St. Gallen, Sankt Gallen
University Hospital Zurich /ID# 266142, Zurich, Zuerich
Kaohsiung Chang Gung Memorial Hospital /ID# 264619, Kaohsiung City, Kaohsiung
National Taiwan University Hospital /ID# 264618, Taipei City, Taipei
Taichung Veterans General Hospital /ID# 270741, Taichung, Not set
Mackay Memorial Hospital /ID# 263661, Taipei City, Not set
Taipei Veterans General Hospital /ID# 265879, Taipei City, Not set
Linkou Chang Gung Memorial Hospital /ID# 264620, Taoyuan City, Not set
Queen Margaret Hospital /ID# 264198, Dunfermline, Fife
Gloucestershire Royal Hospital /ID# 265848, Gloucester, Gloucestershire
Disc_Barts Health NHS Trust - The Royal London Hospital /ID# 264121, London, Greater London
Harrogate District Hospital /ID# 265632, Harrogate, North Yorkshire
Bristol Royal Infirmary /ID# 263937, Bristol, Not set
Conditions: Hidradenitis Suppurativa
253 - 264 of 3905